In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains
Related Experiment Video
Updated: Aug 19, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Abstract:
Rosamicin was significantly more active against Haemophilus and Neisseria than are many antibiotics currently used to treat or prevent infection caused by these organisms. This enhanced activity was also observed against penicillinase-producing strains.
Insights
Rosamicin shows greater activity against Haemophilus and Neisseria bacteria compared to current antibiotics. This includes effectiveness against strains that produce penicillinase, offering a potential new treatment option.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Haemophilus and Neisseria species are significant human pathogens.
- Current antibiotic therapies face challenges with resistance, including penicillinase production.
Purpose of the Study:
- To evaluate the antimicrobial activity of Rosamicin against key bacterial pathogens.
- To compare Rosamicin's efficacy with existing antibiotics for Haemophilus and Neisseria infections.
Main Methods:
- In vitro susceptibility testing was performed.
- Comparative analysis of Rosamicin against standard antibiotics was conducted.
Main Results:
- Rosamicin demonstrated significantly enhanced activity against Haemophilus and Neisseria.
- This heightened efficacy extended to penicillinase-producing strains of these bacteria.
Conclusions:
- Rosamicin exhibits potent antimicrobial properties against important bacterial targets.
- Its activity against penicillinase-producing strains suggests clinical utility in treating resistant infections.
Related Concept Videos
Production of Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

